Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin versus aspirin for prevention of deep vein thrombosis after anterior cruciate ligament reconstruction
IRCT20190325043107N7Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in deep vein thrombosis (DVT) comparing Enoxaparin with Aspirin (2 arms). Primary endpoint: Deep vein thrombosis. Started Jul 2019; status: completed.
02
Drugs
enoxaparinaspirin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on IRCT20190325043107N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N7.